In March, a three-judge panel of the 10th Circuit Court of Appeals upheld a lower court’s ruling, issuing a unanimous decision that leaned heavily on the Unlawful Inclosures Act — a law Congress ...

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common ...

Sens. Sanders' and King's proposed ban misunderstands drug ads' benefits, which empower patients and enhance their health ...

Here is a close look at AppLovin stock, including where the shares of the tech company could be headed through the rest of ...

Live Updates Live Coverage Has Ended Thursday Wrap-up 4:17 pm The Vanguard S&P 500 ETF closed at 584.27 Thursday, down 0.4%.

High yield can sometimes lead to high turnover. Income investors may need to be prepared to sell high-yield dividend stocks quickly if their dividends appear to be at risk. However, it doesn't have to ...

Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios amid geopolitical and macroeconomic uncertainties.

Shares of The TJX Companies, Inc. TJX +5.44% Get Free Report rose sharply during Wednesday's session after the company beat ...

The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli ...

Shares of Rocket Pharmaceuticals, Inc. RCKT rose sharply in pre-market trading after the company disclosed that the FDA has ...

Tier-two pharma picks show solid fundamentals, but Eli Lilly (LLY) stock stands out for its growth potential. Read here for ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.